These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24245111)
21. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Forster B; Klein A; Szeimies RM; Maisch T Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354 [TBL] [Abstract][Full Text] [Related]
22. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells. Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723 [TBL] [Abstract][Full Text] [Related]
23. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Ross EV; Romero R; Kollias N; Crum C; Anderson RR Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233 [TBL] [Abstract][Full Text] [Related]
24. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942 [TBL] [Abstract][Full Text] [Related]
25. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation. Togsverd-Bo K; Lerche CM; Philipsen PA; Poulsen T; Wulf HC; Haedersdal M Exp Dermatol; 2012 Apr; 21(4):260-4. PubMed ID: 22320713 [TBL] [Abstract][Full Text] [Related]
26. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995 [TBL] [Abstract][Full Text] [Related]
27. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. Shen SC; Lee WR; Fang YP; Hu CH; Fang JY J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590 [TBL] [Abstract][Full Text] [Related]
28. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Van der Veen N; De Bruijn HS; Star WM Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231 [TBL] [Abstract][Full Text] [Related]
29. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy. Jia HR; Jiang YW; Zhu YX; Li YH; Wang HY; Han X; Yu ZW; Gu N; Liu P; Chen Z; Wu FG J Control Release; 2017 Jun; 255():231-241. PubMed ID: 28442408 [TBL] [Abstract][Full Text] [Related]
30. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources. Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358 [TBL] [Abstract][Full Text] [Related]
31. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models. Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253 [TBL] [Abstract][Full Text] [Related]
32. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792 [TBL] [Abstract][Full Text] [Related]
33. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406 [TBL] [Abstract][Full Text] [Related]
34. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018 [TBL] [Abstract][Full Text] [Related]
35. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pierre MB; Ricci E; Tedesco AC; Bentley MV Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572 [TBL] [Abstract][Full Text] [Related]
36. Effect of LaF Tavakkoli F; Zahedifar M; Sadeghi E Photodiagnosis Photodyn Ther; 2018 Mar; 21():306-311. PubMed ID: 29331661 [TBL] [Abstract][Full Text] [Related]
37. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. van der Veen N; de Bruijn HS; Berg RJ; Star WM Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]
39. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589 [TBL] [Abstract][Full Text] [Related]
40. Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. Ding H; Sumer BD; Kessinger CW; Dong Y; Huang G; Boothman DA; Gao J J Control Release; 2011 May; 151(3):271-7. PubMed ID: 21232562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]